Cabot (CBT) closed at $74.43 on October 30, 2026, up 0.8% from the previous close, on volume of 481,312 shares (30-day average 378,762).
Data as of October 30, 2026.
30-Oct-2026
No headlines found.
Cabot Corporation to Announce Fourth Quarter Fiscal 2026 Operating Results
Globe Newswire (Tue, 13-Oct 4:04 PM ET)
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
Cabot Corporation Appoints Steve Delahunt as Interim Chief Financial Officer
Globe Newswire (Tue, 15-Sep 8:30 AM ET)
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029
Globe Newswire (Wed, 12-Aug 5:35 PM ET)
Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results
Globe Newswire (Mon, 3-Aug 4:31 PM ET)
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Cabot trades on the NYSE stock market under the symbol CBT.
As of October 30, 2026, CBT stock price climbed to $74.43 with 481,312 million shares trading.
CBT has a beta of 0.43, meaning it tends to be less sensitive to market movements. CBT has a correlation of 0.03 to the broad based SPY ETF.
CBT has a market cap of $3.84 billion. This is considered a Mid Cap stock.
Last quarter Cabot reported $982 million in Revenue and $1.67 earnings per share. This beat revenue expectation by $57 million and exceeded earnings estimates by $.02.
In the last 3 years, CBT traded as high as $117.46 and as low as $58.33.
The top ETF exchange traded funds that CBT belongs to (by Net Assets): AVUV, IJH, VTI, IWM, VB.
CBT has outperformed the market in the last year with a price return of +12.9% while the SPY ETF gained +12.3%. However, in the short term, CBT had mixed performance relative to the market. It has underperformed in the last 3 months, returning -15.1% vs +2.1% return in SPY. But in the last 2 weeks, CBT shares have fared better than the market returning +0.2% compared to SPY -1.0%.
CBT support price is $72.77 and resistance is $74.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBT shares will trade within this expected range on the day.